Shigella type III secretion effectors: how, where, when, for what purposes?

Area of Science:

• Microbiology
• Cell Biology
• Immunology

Background:

• Shigella spp. are human pathogens causing shigellosis.
• They utilize a type III secretion apparatus (T3SA) to deliver ~25-30 effector proteins into host cells.
• T3SA activity is triggered by bacterial contact with host cells.

Purpose of the Study:

• To elucidate the distinct roles of Shigella effectors in host cell interaction.
• To understand the regulation of effector production by the T3SA.
• To investigate how effectors modulate host cell signaling and immune evasion.

Main Methods:

• Structural and functional analyses of Shigella effector proteins.
• Investigating the T3SA-mediated injection mechanism.
• Studying the impact of effectors on host cell actin cytoskeleton and immune pathways.

Main Results:

• Two effector sets identified: one for actin reorganization and bacterial entry, another for modulating host immune responses.
• Effectors promoting bacterial entry are produced independently of T3SA activation.
• Effectors involved in immune suppression are produced following T3SA activation.

Conclusions:

• Shigella employs a dual strategy with distinct effector sets for invasion and immune evasion.
• The T3SA plays a crucial role in regulating the delivery of immune-modulating effectors.
• Understanding these mechanisms is key to developing therapies against shigellosis.